Relation of N-Terminal Pro B-Type Natriuretic Peptide Levels After Symptom-Limited Exercise to Baseline and Ischemia Levels

American Journal of Cardiology

Volumn 103, Issue 5, 2009, Pages 604-610

  van der Zee, P Marc ^a   Verberne, Hein J ^a   van Spijker, Rianne C ^a   van Straalen, Jan P ^a   Fischer, Johan C ^a   Sturk, Augueste ^a   van Eck Smit, Berthe L F ^a   de Winter, Robbert J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; CYSTATIN C;

ADULT; AGED; ARTICLE; EXERCISE; FEMALE; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCINTIANGIOCARDIOGRAPHY; TIME;

ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 60249101705     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.11.006     Document Type: Article

References (29)

1. Levin E.R., Gardner D.G., and Samson W.K. Natriuretic peptides. N Engl J Med 339 (1998) 321-328
2. Bettencourt P., Azevedo A., Pimenta J., Frioes F., Ferreira S., and Ferreira A. N-Terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 110 (2004) 2168-2174
3. de Winter R.J., Stroobants A., Koch K.T., Bax M., Schotborgh C.E., Mulder K.J., Sanders G.T., van Straalen J.P., Fischer J., Tijssen J.G., and Piek J.J. Plasma N-terminal pro-B-type natriuretic peptide for prediction of death or nonfatal myocardial infarction following percutaneous coronary intervention. Am J Cardiol 94 (2004) 1481-1485
4. Kragelund C., Gronning B., Kober L., Hildebrandt P., and Steffensen R. N-Terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med 352 (2005) 666-675
5. Weber M., Dill T., Arnold R., Rau M., Ekinci O., Muller K.D., Berkovitsch A., Mitrovic V., and Hamm C. N-Terminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris. Am Heart J 148 (2004) 612-620
6. de Lemos J.A., Morrow D.A., Bentley J.H., Omland T., Sabatine M.S., McCabe C.H., Hall C., Cannon C.P., and Braunwald E. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 345 (2001) 1014-1021
7. Clerico A., Caprioli R., Del Ry S., and Giannessi D. Clinical relevance of cardiac natriuretic peptides measured by means of competitive and non-competitive immunoassay methods in patients with renal failure on chronic hemodialysis. J Endocrinol Invest 24 (2001) 24-30
8. Wiese S., Breyer T., Dragu A., Wakili R., Burkard T., Schmidt-Schweda S., Fuchtbauer E.M., Dohrmann U., Beyersdorf F., Radicke D., and Holubarsch C.J. Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium: influence of angiotensin II and diastolic fiber length. Circulation 102 (2000) 3074-3079
9. Yasue H., Yoshimura M., Sumida H., Kikuta K., Kugiyama K., Jougasaki M., Ogawa H., Okumura K., Mukoyama M., and Nakao K. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 90 (1994) 195-203
10. Goetze J.P., Gore A., Moller C.H., Steinbruchel D.A., Rehfeld J.F., and Nielsen L.B. Acute myocardial hypoxia increases BNP gene expression. FASEB J 18 (2004) 1928-1930
11. Sabatine M.S., Morrow D.A., de Lemos J.A., Omland T., Desai M.Y., Tanasijevic M., Hall C., McCabe C.H., and Braunwald E. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia. J Am Coll Cardiol 44 (2004) 1988-1995
12. De Puey E.G. Updated imaging guidelines for nuclear cardiology procedures, part 1. J Nucl Cardiol 8 (2001) G5-G58
13. Gibbons R.J., Balady G.J., Bricker J.T., Chaitman B.R., Fletcher G.F., Froelicher V.F., Mark D.B., McCallister B.D., Mooss A.N., O'Reilly M.G., et al. ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). J Am Coll Cardiol 40 (2002) 1531-1540
14. Germano G., Erel J., Lewin H., Kavanagh P.B., and Berman D.S. Automatic quantitation of regional myocardial wall motion and thickening from gated technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 30 (1997) 1360-1367
15. Germano G., Kiat H., Kavanagh P.B., Moriel M., Mazzanti M., Su H.T., Van Train K.F., and Berman D.S. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 36 (1995) 2138-2147
16. Akincioglu C., Berman D.S., Nishina H., Kavanagh P.B., Slomka P.J., Abidov A., Hayes S., Friedman J.D., and Germano G. Assessment of diastolic function using 16-frame 99mTc-sestamibi gated myocardial perfusion SPECT: normal values. J Nucl Med 46 (2005) 1102-1108
17. Gibbons R.J., Balady G.J., Beasley J.W., Bricker J.T., Duvernoy W.F., Froelicher V.F., Mark D.B., Marwick T.H., McCallister B.D., Thompson Jr. P.D., et al. ACC/AHA guidelines for exercise testing. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). J Am Coll Cardiol 30 (1997) 260-311
18. James S.K., Lindahl B., Siegbahn A., Stridsberg M., Venge P., Armstrong P., Barnathan E.S., Califf R., Topol E.J., Simoons M.L., and Wallentin L. N-Terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy. Circulation 108 (2003) 275-281
19. Asada J., Tsuji H., Iwasaka T., Thomas J.D., and Lauer M.S. Usefulness of plasma brain natriuretic peptide levels in predicting dobutamine-induced myocardial ischemia. Am J Cardiol 93 (2004) 702-704
20. Bibbins-Domingo K., Ansari M., Schiller N.B., Massie B., and Whooley M.A. B-Type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul Study. Circulation 108 (2003) 2987-2992
21. Palumbo B., Siepi D., Lupattelli G., Sinzinger H., Fiorucci G., Anniboletti P.F., Latini R.A., Mannarino E., and Palumbo R. Usefulness of brain natriuretic peptide levels to discriminate patients with stable angina pectoris without and with electrocardiographic myocardial ischemia and patients with healed myocardial infarction. Am J Cardiol 94 (2004) 780-783
22. Sadanandan S., Cannon C.P., Chekuri K., Murphy S.A., Dibattiste P.M., Morrow D.A., de Lemos J.A., Braunwald E., and Gibson C.M. Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction. J Am Coll Cardiol 44 (2004) 564-568
23. Sahinarslan A., Cengel A., Okyay K., Yazc H.U., Elbey S., Cemri M., Ozdemir M., and Timurkaynak T. B-Type natriuretic peptide and extent of lesion on coronary angiography in stable coronary artery disease. Coron Artery Dis 16 (2005) 225-229
24. Möckel M., Müller R., Vollert J., Müller C., Carl A., Peetz D., Post F., Kohse J., and Lackner K. Role of N-terminal pro-B-type natriuretic peptide in risk stratification in patients presenting in the emergency room. Clin Chem 51 (2005) 1624-1631
25. McCullough P.A., Omland T., and Maisel A.S. B-Type natriuretic peptides: a diagnostic breakthrough for clinicians. Rev Cardiovasc Med 4 (2003) 72-80
26. McGregor A., Richards M., Espiner E., Yandle T., and Ikram H. Brain natriuretic peptide administered to man: actions and metabolism. J Clin Endocrinol Metab 70 (1990) 1103-1107
27. Nakamura S., Naruse M., Naruse K., Kawana M., Nishikawa T., Hosoda S., Tanaka I., Yoshimi T., Yoshihara I., Inagami T., et al. Atrial natriuretic peptide and brain natriuretic peptide coexist in the secretory granules of human cardiac myocytes. Am J Hypertens 4 (1991) 909-912
28. Wu A.H., Smith A., Wieczorek S., Mather J.F., Duncan B., White C.M., McGill C., Katten D., and Heller G. Biological variation for N-terminal pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure. Am J Cardiol 92 (2003) 628-631
29. Conraads V., Maeyer C., Beckers P., Possemiers N., Martin M., Van Hoof V., and Vrints C. Exercise-induced biphasic increase in circulating NT-proBNP levels in patients with chronic heart failure. Eur J Heart Fail 10 (2008) 793-795